Table 1 Comparison of the clinical characteristics between the out-of-hospital cardiac arrest patients with good and poor neurologic outcomes at 1 month.
Characteristics | Total (n = 41) | Good neurologic outcome (n = 21) | Poor neurologic outcome (n = 20) | p value |
|---|---|---|---|---|
Age, years | 58.4 (17.3) | 51.9 (14.9) | 65.2 (17.3) | 0.012 |
Male | 28 (68.3%) | 18 (85.7%) | 10 (50.0%) | 0.014 |
Previous medical history | ||||
No comorbid disease | 13 (31.7%) | 10 (47.6%) | 3 (15.0%) | 0.025 |
Hypertension | 10 (24.4%) | 4 (19.0%) | 6 (30.0%) | 0.484 |
Diabetes mellitus | 7 (17.1%) | 2 (9.5%) | 5 (25.0%) | 0.238 |
Congestive heart failure | 3 (7.3%) | 1 (4.8%) | 2 (10.0%) | 0.606 |
Chronic kidney disease | 3 (7.3%) | 0 (0%) | 3 (15.0%) | 0.107 |
Arrest characteristics | ||||
Presence of a witness | 28 (68.3%) | 18 (85.7%) | 10 (50.0%) | 0.014 |
Bystander CPR | 25 (61.0%) | 14 (66.7%) | 11 (55.0%) | 0.444 |
Initial shockable rhythm | 24 (58.5%) | 18 (85.7%) | 6 (30.0%) | < 0.001 |
No flow time, min | 0.0 (0.0–5.0) | 0.0 (0.0–8.5) | 1.0 (0.0–4.5) | 0.877 |
Resuscitation duration, min | 18.0 (7.5–37.5) | 11.0 (6.5–24.5) | 34.0 (11.0–41.5) | 0.022 |
Time from ROSC to target temperature, min | 437 (236.4) | 423 (189.5) | 453 (284.0) | 0.696 |
Time from ROSC to EEG, hours | 21.0 (11.5–37.0) | 19.0 (8.5–39.5) | 22.5 (17.3–36.8) | 0.481 |
Treated sedative | 41 (100.0%) | 21 (100.0%) | 20 (100.0%) | 1.000 |
Propofol | 36 (87.8%) | 19 (90.5%) | 17 (85.0%) | 0.486 |
Midazolam | 6 (14.6%) | 5 (23.8%) | 1 (5.0%) | 0.102 |
Fentanyl | 37 (90.2%) | 19 (90.5%) | 18 (90.0%) | 0.481 |
Remifentanil | 16 (39.2%) | 8 (38.1%) | 8 (40.0%) | 0.574 |
Morphine | 18 (43.9%) | 9 (42.9%) | 9 (45.0%) | 0.567 |
Target temperature | Total (n = 41) | 33 °C (n = 34) | 36 °C (n = 7) | |
Good neurologic outcome | 21 (51.2%) | 19 (55.9%) | 2 (28.6%) | 0.238 |
